Biocon Limited



Biocon Limited has informed the Exchange regarding a press release dated August 03, 2026, titled “Biocon Announces U.SCommercial Launch of Yesafili , a Biosimilar to Regeneron s Eylea® 2 mg”|SUBJECT: Press Release



Source link

Related Posts

3i Infotech Limited

3i Infotech Limited has informed the Exchange about Transcripts – earnings or quarterly calls |SUBJECT: Analyst/Investor Meet Para A-XBRL Source…

Persistent Systems Limited

Persistent Systems Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026|SUBJECT: Outcome…

Tata Power Company Limited

Tata Power Company Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company |SUBJECT: Pendency…

Leave a Reply

Your email address will not be published. Required fields are marked *